Clinical efficacy and safety of apatinib in patients with advanced colorectal cancer as the late-line treatment

There is currently no standard therapeutic regimen available for patients with advanced colorectal cancer in whom the disease continues to progress after 2 or more lines of chemotherapy. The purpose of this study is to investigate the efficacy and safety of apatinib in patients with advanced colorec...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xiaoli, Li, Hualan, Liu, Zhihui, Liao, Sina, Li, Qian, Liang, Chaoyong, Huang, Yu, Xie, Mingzhi, Wei, Junbao, Li, Yongqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320137/
https://www.ncbi.nlm.nih.gov/pubmed/30558053
http://dx.doi.org/10.1097/MD.0000000000013635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320137/
https://www.ncbi.nlm.nih.gov/pubmed/30558053
http://dx.doi.org/10.1097/MD.0000000000013635

Ejemplares similares